CLEO Diagnostics LtdASX: COV

Appendix 4G and Corporate Governance Statement

· Issued by CLEO Diagnostics Ltd via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/appendix-4g-and-corporate-governance-statement-109

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Cleo Diagnostics Ltd ABN/ARBN Financial year ended: 13 655 717 169 30 June 2026 Our...

View Attachment

6ix hasn’t read this filing yet.

CLEO Diagnostics Ltd on 6ix

Earlier from CLEO Diagnostics

Later from CLEO Diagnostics

All CLEO Diagnostics news releases